Presence of Parvovirus B19 but Not Herpesvirus Genome in Acute Skin Rash after Allogeneic Stem Cell Transplantation Correlates with Outcome
Open Access
- 9 September 2020
- journal article
- research article
- Published by S. Karger AG in Acta Haematologica
- Vol. 144 (2), 202-211
- https://doi.org/10.1159/000509739
Abstract
Introduction: Skin rash is a first symptom of acute graft-versus-host disease (GvHD) after allogeneic stem cell transplantation (ASCT) but can also be caused by viruses. The relevance of virus DNA analyses in skin rash for diagnosis and clinical outcome is unknown. Objectives: To record the frequencies of detection of herpes and parvovirus B19 (ParvoB19) DNA in skin rash within 100 days after ASCT and to analyze their relevance for diagnosis, clinical course, and non-relapse mortality (NRM). Methods: We retrospectively identified 55 patients with virus DNA analysis for CMV, EBV, HHV6, HHV8, HSV, VZV, or ParvoB19. We assessed the rate of virus DNA detection and studied associations with histological diagnosis, virus DNA from concomitantly analyzed blood, clinical presentation, exanthema treatment, and NRM. Results: CMV, EBV, HHV6, HHV8, HSV, VZV and ParvoB19 DNA were detected in 12.5, 11.8, 10, 0, 0, 2.9, and 26.7% of exanthemas. Histopathological diagnosis was not associated with virus polymerase chain reaction (PCR) results. Detection of CMV, EBV, or HHV6 DNA but not ParvoB19 in skin and blood was associated with PCR results (p = 0.016; p < 0.001; p = 0.067; p = n.a.). Detection of CMV, EBV, HHV6, or ParvoB19 DNA in the skin was not significantly associated with patient, ASCT, or GvHD characteristics. Detection of ParvoB19 but not herpes virus DNA was associated with less immunosuppressive treatment (p = 0.015) and lower NRM (p = 0.041). In multivariate analyses, detection of ParvoB19 was associated with a lower NRM. Conclusions: Detection of ParvoB19 DNA in exanthema after ASCT might be associated with lower NRM.Keywords
This publication has 49 references indexed in Scilit:
- Alloreactivity of Virus-Specific T Cells: Possible Implication of Graft-Versus-Host Disease and Graft-Versus-Leukemia EffectsFrontiers in Immunology, 2013
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationThe New England Journal of Medicine, 2010
- Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2010
- Parvovirus B19 DNA Is Commonly Harboured in Human SkinDermatology, 2010
- Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantationBlood, 2009
- Cutaneous Graft-versus-Host Disease: A Guide for the DermatologistDermatology, 2008
- Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipientsBone Marrow Transplantation, 2007
- Parvovirus B19 Infection after Transplantation: A Review of 98 CasesClinical Infectious Diseases, 2006
- Clinical Outcomes of Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell TransplantationClinical Infectious Diseases, 2005
- Clinical aspects of cmv infection after stem cell transplantationHuman Immunology, 2004